Location History:
- Mount Vernon, ME (US) (2002)
- San Bruno, CA (US) (2015 - 2024)
- South San Francisco, CA (US) (2019 - 2024)
- Brisbane, CA (US) (2023 - 2024)
Company Filing History:
Years Active: 2002-2025
Title: The Innovative Contributions of Eric Andrew Evans in Genetic Detection
Introduction
Eric Andrew Evans, based in San Bruno, CA, has made significant advancements in the field of genetic detection through his impressive portfolio of 14 patents. His innovative work primarily focuses on methods for detecting DNA in biological samples, providing essential tools for the early diagnosis of diseases, including various cancers and genetic disorders.
Latest Patents
Among Eric's latest patents are innovative methods for detecting DNA in samples, which allow for the identification of unique genetic signatures, including mutations linked to diseases. These methods enhance sensitivity, enabling non-invasive detection at minimal proportions of mutated sequences compared to normal sequences or a reference human genome. Another noteworthy patent involves new techniques for preparing a DNA fraction that is enriched with circulating tumor DNA. This patent outlines a laboratory execution system designed to automate laboratory processes, featuring a centralized data management system that streamlines complex analytical functions.
Career Highlights
Eric has contributed to the field of genetic testing and diagnostics while working at prominent companies such as Myriad Women's Health and Counsyl. His expertise in DNA detection technologies has placed him at the forefront of innovations that drive progress in understanding genetic conditions and enhancing patient outcomes.
Collaborations
Throughout his career, Eric has collaborated with talented professionals including Clement S. Chu and Imran Saeedul Haque. These partnerships have fostered a rich environment for knowledge exchange and innovation, enabling the development of cutting-edge technologies in genetic research.
Conclusion
In conclusion, Eric Andrew Evans exemplifies the spirit of innovation within the realm of genetic detection. His contributions through his patents are instrumental in advancing methodologies that improve disease diagnosis and treatment. As the field of genetics continues to evolve, the impact of Eric's work is likely to play a crucial role in shaping the future of biomedical research and its applications.